In most human immunodeficiency virus type 1 (HIV-1)-infected individuals who achieve viral loads of /ml during highly active antiretroviral therapy (HAART), low levels of plasma virus remain detectable for years by ultrasensitive methods. The relative contributions of ongoing virus replication and virus production from HIV-1 reservoirs to persistent low-level viremia during HAART remain controversial. HIV-1 vaccination of HAART-treated individuals provides a model for examining low-level viremia, as immunizations may facilitate virus replication and sequence evolution. In a phase 1 trial of modified vaccinia virus Ankara/fowlpox virus-based HIV-1 vaccines in 20 HIV-infected young adults receiving HAART, we assessed the prevalence of low-lev...
Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads. Howeve...
Plasma viral load and CD4 counts are effective for clinical monitoring, but they do not give a full ...
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antire...
In most human immunodeficiency virus type 1 (HIV-1)-infected individuals who achieve viral loads of ...
A significant percentage of human immunodeficiency virus type 1 (HIV-1)–infected persons treated wit...
Despite successful antiretroviral therapy (ART), low-level viremia (LLV) may be intermittently detec...
The clinical significance and cellular sources of residual human immunodeficiency virus type 1 (HIV-...
Population sequencing was performed for persons identified with persistent low-level viremia in 2 cl...
<div><p>Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads...
Current antiretroviral therapy is effective in suppressing but not eliminating HIV-1 infection. Unde...
Residual viremia is common during antiretroviral therapy (ART) and could be caused by ongoing low-le...
Low levels of plasma viremia (below 50 copies/ml of HIV-1 RNA) can be detected in the majority of HI...
To provide insight into the dynamics and source of residual viremia in human immunodeficiency virus ...
Thesis (Ph.D.)--University of Washington, 2020Despite antiretroviral therapy (ART) that suppresses H...
AbstractThree HIV-1-infected individuals, on virally-suppressive highly active anti-retroviral thera...
Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads. Howeve...
Plasma viral load and CD4 counts are effective for clinical monitoring, but they do not give a full ...
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antire...
In most human immunodeficiency virus type 1 (HIV-1)-infected individuals who achieve viral loads of ...
A significant percentage of human immunodeficiency virus type 1 (HIV-1)–infected persons treated wit...
Despite successful antiretroviral therapy (ART), low-level viremia (LLV) may be intermittently detec...
The clinical significance and cellular sources of residual human immunodeficiency virus type 1 (HIV-...
Population sequencing was performed for persons identified with persistent low-level viremia in 2 cl...
<div><p>Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads...
Current antiretroviral therapy is effective in suppressing but not eliminating HIV-1 infection. Unde...
Residual viremia is common during antiretroviral therapy (ART) and could be caused by ongoing low-le...
Low levels of plasma viremia (below 50 copies/ml of HIV-1 RNA) can be detected in the majority of HI...
To provide insight into the dynamics and source of residual viremia in human immunodeficiency virus ...
Thesis (Ph.D.)--University of Washington, 2020Despite antiretroviral therapy (ART) that suppresses H...
AbstractThree HIV-1-infected individuals, on virally-suppressive highly active anti-retroviral thera...
Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads. Howeve...
Plasma viral load and CD4 counts are effective for clinical monitoring, but they do not give a full ...
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antire...